Activity and Safety of Oral Administration of SSR150106XB for the Reduction of Inflammation in Patients With Active Rheumatoid Arthritis

Clinical trial NCT00545454 · COMPLETED

Trial details

NCT number: NCT00545454
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2007-10-01
Primary completion: 2008-06-01
Enrollment: 79

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.